
| Specification | Detail |
| Category | Multi-Pathway Tissue Regeneration & Remodelling |
| Product Name | Glow 70mg Blend |
| Composition | GHK-Cu (50mg) + BPC-157 (10mg) + TB-500 (10mg) |
| Total Active API | 70mg |
| Formulation | Sterile Lyophilised Solution in Bacteriostatic Water |
| Delivery Method | 3ml Precision Reconstituted Pen |
| Appearance | Distinct Blue Solution (Due to Copper coordination complex) |
| Purity | Each component validated at >98-99% (HPLC Analysis) |
£179.00
Abstract The Glow 70mg peptide pen represents a sophisticated “Tri-Active” research blend designed to model total tissue regeneration. It combines high-concentrations of three distinct regenerative agents: GHK-Cu (50mg) for collagen synthesis and antioxidant defence, BPC-157 (10mg) for angiogenesis and soft tissue cytoprotection, and TB-500 (10mg) for actin-mediated cell migration. This synergistic formulation allows researchers to investigate the “Remodelling Cascade” in a single administration. Unlike mono-therapy models which target isolated pathways (e.g., only vascularization or only chemotaxis), the Glow 70mg blend provides the comprehensive signaling environment required to simulate accelerated wound healing, dermal rejuvenation, and extracellular matrix (ECM) turnover in complex biological systems.
Primary Biological Pathway: The “Remodelling Triad” The research utility of the Glow 70mg pen lies in the simultaneous activation of three non-overlapping repair mechanisms:
Angiogenesis (BPC-157): Activates the VEGFR2 pathway and NO system to establish the micro-vasculature required to supply nutrients to the repair site.
Chemotaxis (TB-500): Upregulates actin-sequestering proteins (Thymosin Beta-4), enabling the rapid migration of keratinocytes and fibroblasts into the wound bed.
Matrix Synthesis (GHK-Cu): Stimulates these recruited fibroblasts to synthesize Collagen Type I/III, Elastin, and proteoglycans (Decorin), while simultaneously inhibiting MMPs (Matrix Metalloproteinases) to prevent tissue degradation. Research utilizing this blend investigates the hypothesis that concurrent administration significantly shortens the “lag phase” of wound healing compared to sequential administration.
Secondary Research Finding: Dermal and Epidermal Junction Integrity This blend is the premier reagent for dermatological research. GHK-Cu resets the gene expression of ageing fibroblasts to a “healthier” state, while TB-500 promotes the stratification of the epidermis. The addition of BPC-157 protects the endothelium from oxidative stress. Researchers use the Glow 70mg pen in models of photo-aging or chemical burns to measure the restoration of the Dermal-Epidermal Junction (DEJ) and the tensile strength of the newly formed skin.
Tertiary Research Finding: Anti-Inflammatory Synergy All three peptides exhibit distinct anti-inflammatory properties. GHK-Cu lowers TNF-α and suppresses iron-mediated oxidation; BPC-157 modulates the arachidonic acid cascade; TB-500 reduces the production of pro-inflammatory cytokines. The 70mg blend is utilised in models of chronic inflammatory skin diseases (e.g., psoriasis or eczema models) to quantify the reduction in erythema and edema, assessing whether the “cocktail” approach offers superior resolution of inflammation compared to corticosteroids.
Long-term Genomic and Safety Observations Genomic profiling studies regarding this triad focus on Fibrosis Prevention. While promoting collagen is good, over-expression leads to scarring. GHK-Cu specifically modulates the breakdown of large collagen aggregates (via stimulation of specific metalloproteinases). Studies using this blend monitor TGF-β signaling pathways to verify that the accelerated healing results in organised tissue regeneration rather than disordered scar tissue formation.
Purity: Each component is individually validated via High-Performance Liquid Chromatography (HPLC) prior to blending. We strictly control the stoichiometry of the mix to ensure no chemical interaction occurs between the copper peptide and the free amines of the BPC/TB sequences during storage.
Appearance: The 3ml pen contains a deep blue, sterile liquid. This colour is intrinsic to the Copper(II) ion in the GHK-Cu complex and serves as a visual indicator of oxidation state integrity.
Precision: The pen delivery system allows for the administration of this complex blend in a single step. This is critical for reducing “needle fatigue” in animal models that would otherwise require three separate injections to achieve the same pharmacological environment.
Storage: The product must be stored at 2∘C to 8∘C.
Refrigeration and Shelf Life The Glow 70mg Pen contains a stable solution, but the complexity of the blend requires strict thermal control. Refrigeration (2∘C to 8∘C) is mandatory. The shelf life is 12 months in the sealed state. Once the pen is accessed, the bacteriostatic environment preserves the solution for 28 days.
Shipping Stability We utilise medical-grade thermal packaging. The peptide is stable for up to 72 hours at ambient UK temperatures. However, to maintain the copper coordination geometry and prevent peptide-peptide interaction, we strongly recommend selecting the fastest available shipping option.
Freezing Warning Strictly avoid freezing. Freezing is catastrophic for GHK-Cu (causing dissociation of the copper ion) and can induce aggregation in BPC-157. Upon thawing, the solution may lose its characteristic blue hue (turning clear or precipitating brown), indicating chemical breakdown. A frozen/thawed pen is experimentally worthless and must be discarded.
The Glow 70mg Pen is the definitive tool for Holistic Regenerative Research. Attempting to manually mix GHK-Cu powder (hygroscopic/acidic) with BPC-157 and TB-500 in the lab is prone to pH incompatibilities and precipitation events.
Our Glow 70mg pen provides a pre-formulated, pH-balanced, and sterile solution. It allows researchers to bypass the formulation challenges and immediately focus on the macroscopic endpoints of tissue repair, providing a robust “all-in-one” reagent for high-impact wound healing and anti-ageing studies.
For researchers wishing to isolate the specific contributions of each pathway, we recommend examining:
GHK-Cu 50mg: (For pure collagen/remodelling research).
BPC-157 10mg: (For pure angiogenesis/GI research).
TB-500 10mg: (For pure cell migration/actin research).
This product is strictly for Research Use Only (RUO). It is not intended for human consumption, injection (e.g., for cosmetic skin treatments, injury recovery, or anti-ageing therapy), therapeutic use, or diagnostic procedures. The information provided is for educational and scientific reference only. Purchase is restricted to verified research institutions and qualified individuals. Any evidence of intended misuse for human application will result in immediate order cancellation and blacklisting, in compliance with UK research chemical regulations.
Explore our high-purity compounds — including Retatide (Retatrutide 30 mg), Semaglutide, and more.
Fast UK shipping. Lab-tested quality. Strictly for research use only.